How can we manage patients over forty with endometriosis?

Engin Oral, Oral E, Inceboz U, Umit Inceboz, Ümit İnceboz
Minerva medica · 2020 · vol. 111(1) , pp. 62–67 · doi:10.23736/s0026-4806.19.06377-8 · PMID:31828985 · W2996672164
Review OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper discusses management strategies for peri/postmenopausal endometriosis in women over forty, addressing concerns about malignant transformation based on current scientific evidence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Peri/postmenopausal endometriosis is not as rare as once we thought. Accumulated data revealed that around 1/3-1/4 of women with surgically-diagnosed endometriosis after the age of 40. The uneasiness of the issue of malignant transformation or malignancy in such women created a challenge for us. Here the management strategy for women with endometriosis after the age of 40 is discussed in the light of scientific evidence.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Adenomyosis Adenomyosis Adenomyosis Adult Adult Aged Aged Aged, 80 and over Aged, 80 and over Age Factors Age Factors Asymptomatic Diseases Asymptomatic Diseases Cell Transformation, Neoplastic Cell Transformation, Neoplastic Cell Transformation, Neoplastic Endometriosis Endometriosis Endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (29)

Cited by (1)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:26:07.973840+00:00
unpaywall
last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0 · commercial use OK